Dr Amin Asfor
Academic and research departments
School of Veterinary Medicine, Faculty of Health and Medical Sciences.About
Biography
After completing his undergraduate studies in Veterinary Medicine from Alexandria University, Amin Asfor obtained a PhD in Molecular Virology and was trained as a virologist in Royal Veterinary College, University of London and at APHA (Weybridge). Amin has joined the Pirbright institute as Postdoctoral Research Scientist. Since 2009, he was involved in several scientific projects to understand picornaviruses antigenicity and to develop novel immunoassays for vaccine quality control and postvaccination monitoring. Later, Amin got promoted to Senior Scientist, and he is holding research projects to develop immunoassays for FMDV and to develop a multivalent vaccine for avian species including infectious bursal disease and avian coronaviruses. In 2020, Amin took up the position of teaching fellow of virology and immunology at the University of Surrey. Amin’s research focuses on translational science exploring virus antigenicity, mechanisms of viral immune escapes and emerging of new variants, and to develop platforms for vaccine development.
Areas of specialism
Affiliations and memberships
Member of the British society for Immunology
Member of the American Society of Virology (ASV)
Member of the American Society for Microbiology (ASM)
News
In the media
Supervision
Postgraduate research supervision
PhD students:
- Sophie Harding (July 2025-2029)- PI Supervisor
- Samirah Mannan (Oct 2024-2028) - PI Supervisor
- Abdelaziz Yassin (Sept 2021-2025) - PI Supervisor
- Hannah Raistrick (Sep 2022- Sept 2026) - Co-Supervisor
- Connie Dummer (Sep 2022- Sep 2026) - Co-Supervisor
- Benedicto Byamukama (Jan 2023-2026) - Co-Supervisor
- Megan Elizabeth Golding (Collaborative) PT
- Bailey Carol Clark(Collaborative)
- Afroditi Savva (Collaborative) PT
MSc Students:
- Al Handyside (Sch of Biosci & Med) (2023-2024)- Principal supervisor
- Ugo Ihearahu (Sch of Biosci & Med) (2021-2022) - Principal supervisor
Undergraduate students' research:
I have supervised at least 2 research projects each year since 2021
Sustainable development goals
My research interests are related to the following:
Publications
Introduction: Foot-and-mouth disease virus (FMDV) has a hypervariable G-H loop region within the VP1 capsid protein. This structure is associated with virus neutralisation and contains the virus attachment motif (RGD) which binds to the cellular integrin receptor facilitating virus entry for all seven FMDV serotypes. Methods: Six monoclonal antibodies (Mabs) were tested against 10 peptides representing the wild-type G-H loops of serotypes O, A, SAT1, and SAT2. D9 and B2 Mabs were raised against serotype O and tested against three more sets of peptides: (1) nine overlapping peptides with one amino acid difference, (2) alanine scanning peptide, both for O1K strain and (3) four mutated peptides one for A22 and three for SAT2 strains in the enzyme-linked immunosorbent assay format with correlation to virus neutralisation test. Results: The D9 Mab was bound to peptides corresponding to the G-H loops of serotype O, A, and SAT1 strains, but only neutralised serotype O and SAT1 strains in the virus neutralisation test. The B2 Mab is also bound to serotype O and SAT1 but only neutralised serotype O. Using a set of overlapping peptides, the binding region for the D9 Mab was confirmed as amino acid positions 144, 147 and 148. An additional critical amino acid residue at position 145R was identified using a set of alanine scanning peptides. The binding region for B2 Mab appears to be upstream of RGD as B2 showed lower binding to peptides lacking the first three amino acids of the GH-loop peptides. These critical amino acids were further confirmed by designing modified SAT2 and A peptides at these positions, which led to a significant improvement in the binding ability of D9 but not B2. Conclusion: These findings help to map cross-reactive epitopes within the G-H loop which may contribute to the inter-serotypic cross-reactivity observed in diagnostic serological assays giving insights that motivate the design of custom peptides that have improved serotype specificity.